Article
Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.
Gynecologic oncology - 1 Oct 2014
Verhoef Viola M J, Heideman Daniëlle A M, van Kemenade Folkert J, Rozendaal Lawrence, Bosgraaf Remko P, Hesselink Albertus T, Bekkers Ruud L M, Massuger Leon F A G, Steenbergen Renske D M, Snijders Peter J F, Berkhof Johannes, Meijer Chris J L M
Abstract excerpt
OBJECTIVES: Methylation marker analysis using bi-marker panel MAL/miR-124-2 is a promising triage test for identifying cervical (pre)cancer in high-risk human papillomavirus (hrHPV) positive women. Bi-marker panel MAL/miR-124-2 can be applied directly on self-sampled cervico-vaginal material and its sensitivity is non-inferior to that of cytology, yet at the cost of more colposcopy referrals. Our objective was to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
